Systematic Evaluation of Genetic Variation at the Androgen Receptor Locus and Risk of Prostate Cancer in a Multiethnic Cohort Study

Freedman, Matthew L.; Pearce, Celeste L.; Penney, Kathryn L.; Hirschhorn, Joel N.; Kolonel, Laurence N.; Henderson, Brian E.; Altshuler, David

Systematic Evaluation of Genetic Variation at the Androgen Receptor Locus and Risk of Prostate Cancer in a Multiethnic Cohort Study

Publication or External Link

http://www.sciencedirect.com/science/article/pii/S0002929707625452

Date

2005

Authors

Citation

Freedman, Matthew L. and Pearce, Celeste L. and Penney, Kathryn L. and Hirschhorn, Joel N. and Kolonel, Laurence N. and Henderson, Brian E. and Altshuler, David (2005) Systematic Evaluation of Genetic Variation at the Androgen Receptor Locus and Risk of Prostate Cancer in a Multiethnic Cohort Study. The American Journal of Human Genetics, 76 (1). pp. 82-90.

DRUM DOI

https://doi.org/10.13016/qxcy-ri6a

Abstract

Repeat length of the CAG microsatellite polymorphism in exon 1 of the androgen receptor (AR) gene has been associated with risk of prostate cancer in humans. This association has been the focus of >20 primary epidemiological publications and multiple review articles, but a consistent and reproducible association has yet to be confirmed. We systematically addressed possible causes of false-negative and false-positive association in >4,000 individuals from a multiethnic, prospective cohort study of prostate cancer, comprehensively studying genetic variation by microsatellite genotyping, direct resequencing of exons in advanced cancer cases, and haplotype analysis across the 180-kb AR genomic locus. These data failed to confirm that common genetic variation in the AR gene locus influences risk of prostate cancer. A systematic approach that assesses both coding and noncoding genetic variation in large and diverse patient samples can help clarify hypotheses about association between genetic variants and disease.